메뉴 건너뛰기




Volumn 16, Issue 8, 2017, Pages 620-629

Prediction of cognition in Parkinson's disease with a clinical–genetic score: a longitudinal analysis of nine cohorts

(26)  Liu, Ganqiang a   Locascio, Joseph J a,b   Corvol, Jean Christophe c,d,e,f   Boot, Brendon b,g   Liao, Zhixiang a   Page, Kara a,g   Franco, Daly a,g   Burke, Kyle a,g   Jansen, Iris E h,i   Trisini Lipsanopoulos, Ana a,g   Winder Rhodes, Sophie j   Tanner, Caroline M k   Lang, Anthony E l   Eberly, Shirley m   Elbaz, Alexis n   Brice, Alexis c,d,e,f   Mangone, Graziella c,d,e,f   Ravina, Bernard o   Shoulson, Ira p   Cormier Dequaire, Florence c,d,e,f   more..

e CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DONEPEZIL; GALANTAMINE; GLUCOSYLCERAMIDASE; RIVASTIGMINE;

EID: 85020512138     PISSN: 14744422     EISSN: 14744465     Source Type: Journal    
DOI: 10.1016/S1474-4422(17)30122-9     Document Type: Article
Times cited : (133)

References (31)
  • 1
    • 0033875826 scopus 로고    scopus 로고
    • What contributes to quality of life in patients with Parkinson's disease?
    • Schrag, A, Jahanshahi, M, Quinn, N, What contributes to quality of life in patients with Parkinson's disease?. J Neurol Neurosurg Psychiatry 69 (2000), 308–312.
    • (2000) J Neurol Neurosurg Psychiatry , vol.69 , pp. 308-312
    • Schrag, A.1    Jahanshahi, M.2    Quinn, N.3
  • 2
    • 84906319104 scopus 로고    scopus 로고
    • Predictors of dementia in Parkinson's disease; findings from a 5-year prospective study using the SCOPA-COG
    • Zhu, K, van Hilten, JJ, Marinus, J, Predictors of dementia in Parkinson's disease; findings from a 5-year prospective study using the SCOPA-COG. Parkinsonism Relat Disord 20 (2014), 980–985.
    • (2014) Parkinsonism Relat Disord , vol.20 , pp. 980-985
    • Zhu, K.1    van Hilten, J.J.2    Marinus, J.3
  • 4
    • 84995745476 scopus 로고    scopus 로고
    • Specifically neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's
    • Liu, G, Boot, B, Locascio, JJ, et al. Specifically neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's. Ann Neurol 80 (2016), 674–685.
    • (2016) Ann Neurol , vol.80 , pp. 674-685
    • Liu, G.1    Boot, B.2    Locascio, J.J.3
  • 5
    • 84990249645 scopus 로고    scopus 로고
    • Survival and dementia in GBA-associated Parkinson's disease: The mutation matters
    • Cilia, R, Tunesi, S, Marotta, G, et al. Survival and dementia in GBA-associated Parkinson's disease: The mutation matters. Ann Neurol 80 (2016), 662–673.
    • (2016) Ann Neurol , vol.80 , pp. 662-673
    • Cilia, R.1    Tunesi, S.2    Marotta, G.3
  • 6
    • 85014252105 scopus 로고    scopus 로고
    • Cognitive decline in Parkinson disease
    • Aarsland, D, Creese, B, Politis, M, et al. Cognitive decline in Parkinson disease. Nat Rev Neurol 13 (2017), 217–231.
    • (2017) Nat Rev Neurol , vol.13 , pp. 217-231
    • Aarsland, D.1    Creese, B.2    Politis, M.3
  • 7
    • 84940759181 scopus 로고    scopus 로고
    • Association between alpha-synuclein blood transcripts and early, neuroimaging-supported Parkinson's disease
    • Locascio, JJ, Eberly, S, Liao, Z, et al. Association between alpha-synuclein blood transcripts and early, neuroimaging-supported Parkinson's disease. Brain 38 (2015), 2659–2671.
    • (2015) Brain , vol.38 , pp. 2659-2671
    • Locascio, J.J.1    Eberly, S.2    Liao, Z.3
  • 8
    • 0025086894 scopus 로고
    • Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group
    • Jankovic, J, McDermott, M, Carter, J, et al. Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group. Neurology 40 (1990), 1529–1534.
    • (1990) Neurology , vol.40 , pp. 1529-1534
    • Jankovic, J.1    McDermott, M.2    Carter, J.3
  • 9
    • 70450192539 scopus 로고    scopus 로고
    • A longitudinal program for biomarker development in Parkinson's disease: a feasibility study
    • Ravina, B, Tanner, C, Dieuliis, D, et al. A longitudinal program for biomarker development in Parkinson's disease: a feasibility study. Mov Disord 24 (2009), 2081–2090.
    • (2009) Mov Disord , vol.24 , pp. 2081-2090
    • Ravina, B.1    Tanner, C.2    Dieuliis, D.3
  • 10
    • 84885666304 scopus 로고    scopus 로고
    • The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort
    • Williams-Gray, CH, Mason, SL, Evans, JR, et al. The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort. J Neurol Neurosurg Psychiatry 84 (2013), 1258–1264.
    • (2013) J Neurol Neurosurg Psychiatry , vol.84 , pp. 1258-1264
    • Williams-Gray, C.H.1    Mason, S.L.2    Evans, J.R.3
  • 11
    • 84881552953 scopus 로고    scopus 로고
    • Determinants of delayed diagnosis in Parkinson's disease
    • Breen, DP, Evans, JR, Farrell, K, Brayne, C, Barker, RA, Determinants of delayed diagnosis in Parkinson's disease. J Neurol 260 (2013), 1978–1981.
    • (2013) J Neurol , vol.260 , pp. 1978-1981
    • Breen, D.P.1    Evans, J.R.2    Farrell, K.3    Brayne, C.4    Barker, R.A.5
  • 12
    • 82755161902 scopus 로고    scopus 로고
    • The Parkinson Progression Marker Initiative (PPMI)
    • Parkinson Progression Marker I. The Parkinson Progression Marker Initiative (PPMI). Prog Neurobiol 95 (2011), 629–635.
    • (2011) Prog Neurobiol , vol.95 , pp. 629-635
  • 13
    • 84949871151 scopus 로고    scopus 로고
    • The NINDS Parkinson's disease biomarkers program
    • Rosenthal, LS, Drake, D, Alcalay, RN, et al. The NINDS Parkinson's disease biomarkers program. Mov Disord 31 (2015), 915–923.
    • (2015) Mov Disord , vol.31 , pp. 915-923
    • Rosenthal, L.S.1    Drake, D.2    Alcalay, R.N.3
  • 14
    • 84939599004 scopus 로고    scopus 로고
    • Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease
    • Nalls, MA, Pankratz, N, Lill, CM, et al. Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease. Nat Genet 46 (2014), 989–993.
    • (2014) Nat Genet , vol.46 , pp. 989-993
    • Nalls, M.A.1    Pankratz, N.2    Lill, C.M.3
  • 15
    • 84866298026 scopus 로고    scopus 로고
    • Calibration of unified Parkinson's disease rating scale scores to Movement Disorder Society-unified Parkinson's disease rating scale scores
    • Goetz, CG, Stebbins, GT, Tilley, BC, Calibration of unified Parkinson's disease rating scale scores to Movement Disorder Society-unified Parkinson's disease rating scale scores. Mov Disord 27 (2012), 1239–1242.
    • (2012) Mov Disord , vol.27 , pp. 1239-1242
    • Goetz, C.G.1    Stebbins, G.T.2    Tilley, B.C.3
  • 17
    • 84918592057 scopus 로고    scopus 로고
    • Conversion between mini-mental state examination, Montreal cognitive assessment, and dementia rating scale-2 scores in Parkinson's Disease
    • van Steenoven, I, Aarsland, D, Hurtig, H, Chen-Plotkin, A, Conversion between mini-mental state examination, Montreal cognitive assessment, and dementia rating scale-2 scores in Parkinson's Disease. Mov Disord 29 (2014), 1809–1814.
    • (2014) Mov Disord , vol.29 , pp. 1809-1814
    • van Steenoven, I.1    Aarsland, D.2    Hurtig, H.3    Chen-Plotkin, A.4
  • 18
    • 4644321549 scopus 로고    scopus 로고
    • Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations
    • Goetz, CG, Poewe, W, Rascol, O, et al. Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations. Mov Disord 19 (2004), 1020–1028.
    • (2004) Mov Disord , vol.19 , pp. 1020-1028
    • Goetz, C.G.1    Poewe, W.2    Rascol, O.3
  • 19
    • 73349120962 scopus 로고    scopus 로고
    • Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease
    • Hoops, S, Nazem, S, Siderowf, AD, et al. Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease. Neurology 73 (2009), 1738–1745.
    • (2009) Neurology , vol.73 , pp. 1738-1745
    • Hoops, S.1    Nazem, S.2    Siderowf, A.D.3
  • 20
    • 38549126646 scopus 로고    scopus 로고
    • Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force
    • Dubois, B, Burn, D, Goetz, C, et al. Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force. Mov Disord 22 (2007), 2314–2324.
    • (2007) Mov Disord , vol.22 , pp. 2314-2324
    • Dubois, B.1    Burn, D.2    Goetz, C.3
  • 21
    • 1542721778 scopus 로고    scopus 로고
    • A short scale for the assessment of motor impairments and disabilities in Parkinson's disease: the SPES/SCOPA
    • Marinus, J, Visser, M, Stiggelbout, AM, et al. A short scale for the assessment of motor impairments and disabilities in Parkinson's disease: the SPES/SCOPA. J Neurol Neurosurg Psychiatry 75 (2004), 388–395.
    • (2004) J Neurol Neurosurg Psychiatry , vol.75 , pp. 388-395
    • Marinus, J.1    Visser, M.2    Stiggelbout, A.M.3
  • 23
    • 80052267232 scopus 로고    scopus 로고
    • MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI
    • Litvan, I, Aarsland, D, Adler, CH, et al. MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI. Mov Disord 26 (2011), 1814–1824.
    • (2011) Mov Disord , vol.26 , pp. 1814-1824
    • Litvan, I.1    Aarsland, D.2    Adler, C.H.3
  • 24
    • 27844469751 scopus 로고    scopus 로고
    • A systematic review of prevalence studies of dementia in Parkinson's disease
    • Aarsland, D, Zaccai, J, Brayne, C, A systematic review of prevalence studies of dementia in Parkinson's disease. Mov Disord 20 (2005), 1255–1263.
    • (2005) Mov Disord , vol.20 , pp. 1255-1263
    • Aarsland, D.1    Zaccai, J.2    Brayne, C.3
  • 25
    • 15044357936 scopus 로고    scopus 로고
    • Survival model predictive accuracy and ROC curves
    • Heagerty, PJ, Zheng, Y, Survival model predictive accuracy and ROC curves. Biometrics 61 (2005), 92–105.
    • (2005) Biometrics , vol.61 , pp. 92-105
    • Heagerty, P.J.1    Zheng, Y.2
  • 26
    • 84902173245 scopus 로고    scopus 로고
    • CSF Abeta42 predicts early-onset dementia in Parkinson disease
    • Alves, G, Lange, J, Blennow, K, et al. CSF Abeta42 predicts early-onset dementia in Parkinson disease. Neurology 8 (2014), 1784–1790.
    • (2014) Neurology , vol.8 , pp. 1784-1790
    • Alves, G.1    Lange, J.2    Blennow, K.3
  • 27
    • 84873647470 scopus 로고    scopus 로고
    • Amyloid is linked to cognitive decline in patients with Parkinson disease without dementia
    • Gomperts, SN, Locascio, JJ, Rentz, D, et al. Amyloid is linked to cognitive decline in patients with Parkinson disease without dementia. Neurology 80 (2013), 85–91.
    • (2013) Neurology , vol.80 , pp. 85-91
    • Gomperts, S.N.1    Locascio, J.J.2    Rentz, D.3
  • 29
    • 65249115240 scopus 로고    scopus 로고
    • Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study
    • Aarsland, D, Bronnick, K, Larsen, JP, Tysnes, OB, Alves, G, Norwegian ParkWest Study G. Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study. Neurology 72 (2009), 1121–1126.
    • (2009) Neurology , vol.72 , pp. 1121-1126
    • Aarsland, D.1    Bronnick, K.2    Larsen, J.P.3    Tysnes, O.B.4    Alves, G.5
  • 30
    • 34447633928 scopus 로고    scopus 로고
    • Evolution of cognitive dysfunction in an incident Parkinson's disease cohort
    • Williams-Gray, CH, Foltynie, T, Brayne, CE, Robbins, TW, Barker, RA, Evolution of cognitive dysfunction in an incident Parkinson's disease cohort. Brain 130 (2007), 1787–1798.
    • (2007) Brain , vol.130 , pp. 1787-1798
    • Williams-Gray, C.H.1    Foltynie, T.2    Brayne, C.E.3    Robbins, T.W.4    Barker, R.A.5
  • 31
    • 41149173996 scopus 로고    scopus 로고
    • The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years
    • Hely, MA, Reid, WG, Adena, MA, Halliday, GM, Morris, JG, The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years. Mov Disord 23 (2008), 837–844.
    • (2008) Mov Disord , vol.23 , pp. 837-844
    • Hely, M.A.1    Reid, W.G.2    Adena, M.A.3    Halliday, G.M.4    Morris, J.G.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.